{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:56:58Z","timestamp":1794851818656,"version":"4.9.1"},"reference-count":203,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPR"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Early recognition of acanthosis nigricans is important because acanthosis\nnigricans can be a cutaneous manifestation of a variety of systemic disorders and, rarely, as a sign\nof internal malignancy.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The purpose of this article is to familiarize pediatricians with the clinical manifestations,\nevaluation, diagnosis, and management of acanthosis nigricans.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A search was conducted in November 2021in PubMed Clinical Queries using the key\nterm \"acanthosis nigricans\". The search strategy included all clinical trials, observational studies,\nand reviews published within the past 10 years. Only papers published in the English literature were\nincluded in this review. The information retrieved from the above search was used in the compilation\nof the present article.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Acanthosis nigricans is characterized by symmetric, hyperpigmented, and velvety plaques\nwith ill-defined borders, typically involving intertriginous areas. Obesity is the most common cause\nof acanthosis nigricans which is increasingly observed in obese children and adolescents and can\nserve as a cutaneous marker of insulin resistance. Early recognition of acanthosis nigricans is important\nbecause acanthosis nigricans can also be a cutaneous manifestation of a variety of systemic\ndisorders and, rarely, as a sign of internal malignancy. This may consist of weight reduction, discontinuation\nof causative drugs, treatment of underlying endocrinopathy, or treatment of an underlying\nmalignancy. For patients with isolated acanthosis nigricans and for those whose underlying\ncause is not amenable to treatment, treatment of the lesion may be considered for cosmetic reasons.\nTopical retinoids, vitamin D analogs, chemical peels, and other keratolytics are often used for the\ntreatment of localized lesions. Seldom, systemic therapy such as oral retinoids may be considered\nfor extensive or generalized acanthosis nigricans and acanthosis nigricans unresponsive to topical\ntherapy. Other uncommon treatment modalities include dermabrasion, laser therapy, and surgical\nremoval.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Although acanthosis nigricans is treatable, a complete cure is difficult to achieve. The\nunderlying cause should be treated, if possible, to resolve and prevent the recurrence of acanthosis\nnigricans. The diagnosis is mainly clinical, based on the characteristic appearance (symmetrically\ndistributed, hyperpigmented, velvety, papillomatous, hyperkeratotic plaques with ill-defined borders)\nand the typical sites (intertriginous areas, flexural area, and skin folds) of the lesions. The diagnosis\nmight be difficult for lesions that have atypical morphology or are in an unusual location.\nClinicians should be familiar with the clinical signs, evaluation, diagnosis, and therapy of acanthosis\nnigricans because of the link between it and underlying diseases.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573396318666220429085231","type":"journal-article","created":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T15:08:32Z","timestamp":1651331312000},"page":"68-82","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Acanthosis Nigricans: An Updated Review"],"prefix":"10.2174","volume":"19","author":[{"given":"Alexander K.C.","family":"Leung","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The University of Calgary, Alberta Children\u2019s Hospital, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Barankin","sequence":"additional","affiliation":[{"name":"Toronto Dermatology Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin Fon","family":"Leong","sequence":"additional","affiliation":[{"name":"Pediatric Institute, Kuala Lumpur General Hospital, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-5529","authenticated-orcid":true,"given":"Kam Lun","family":"Hon","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, The Chinese University of Hong Kong, and Department of Paediatrics and Adolescent Medicine, Hong Kong Children\u2019s Hospital, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.25270\/cfp.2004.10.00001","volume":"3","author":"Leung A.K.","year":"2004","unstructured":"Leung A.K.; Kao C.P.; Childhood acanthosis nigricans. Consultant Pediatrician 2004,3,241-243","journal-title":"Consultant Pediatrician"},{"key":"ref=2","first-page":"253","volume":"2","author":"Leung A.K.C.","year":"2011","unstructured":"Leung A.K.C.; Acanthosis nigricans. Common Problems in Ambulatory Pediatrics: Specific Clinical Problems 2011,2,253-6","journal-title":"Common Problems in Ambulatory Pediatrics: Specific Clinical Problems"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jaad.2006.08.016","volume":"57","author":"Sinha S.","year":"2007","unstructured":"Sinha S.; Schwartz R.A.; Juvenile acanthosis nigricans. J Am Acad Dermatol 2007,57(3),502-508","journal-title":"J Am Acad Dermatol"},{"key":"ref=4","author":"Brady M.F.","year":"2011","unstructured":"Brady M.F.; Rawla P.;  In: StatPearls 2011","journal-title":"In: StatPearls"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0002-9343(89)80149-4","volume":"87","author":"Stuart C.A.","year":"1989","unstructured":"Stuart C.A.; Pate C.J.; Peters E.J.; Prevalence of acanthosis nigricans in an unselected population. Am J Med 1989,87(3),269-272","journal-title":"Am J Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.clindermatol.2015.04.010","volume":"33","author":"Kutlubay Z.","year":"2015","unstructured":"Kutlubay Z.; Engin B.; Bairamov O.; T&#xFC;z&#xFC;n Y.; Acanthosis nigricans: A fold (intertriginous) dermatosis. Clin Dermatol 2015,33(4),466-470","journal-title":"Clin Dermatol"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1590\/S0365-05962012000400002","volume":"87","author":"Kluczynik C.E.","year":"2012","unstructured":"Kluczynik C.E.; Mariz L.S.; Souza L.C.; Solano G.B.; Albuquerque F.C.; Medeiros C.C.; Acanthosis nigricans and insulin resistance in overweight children and adolescents. An Bras Dermatol 2012,87(4),531-537","journal-title":"An Bras Dermatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1651-2227.2006.tb02202.x","volume":"95","author":"Miura N.","year":"2006","unstructured":"Miura N.; Ikezaki A.; Iwama S.; Matsuoka H.; Ito K.; Sugihara S.; Genetic factors and clinical significance of acanthosis nigricans in obese Japanese children and adolescents. Acta Paediatr 2006,95(2),170-175","journal-title":"Acta Paediatr"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S1054-139X(00)00217-2","volume":"28","author":"Mukhtar Q.","year":"2001","unstructured":"Mukhtar Q.; Cleverley G.; Voorhees R.E.; McGrath J.W.; Prevalence of acanthosis nigricans and its association with hyperinsulinemia in New Mexico adolescents. J Adolesc Health 2001,28(5),372-376","journal-title":"J Adolesc Health"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e4711","DOI":"10.1097\/MD.0000000000004711","volume":"95","author":"Novotny R.","year":"2016","unstructured":"Novotny R.; Li F.; Fialkowski M.K.; Prevalence of obesity and acanthosis nigricans among young children in the children\u2019s healthy living program in the United States Affiliated Pacific. Medicine (Baltimore) 2016,95(37),e4711","journal-title":"Medicine (Baltimore)"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/sj.ijo.0802919","volume":"29","author":"Shalitin S.","year":"2005","unstructured":"Shalitin S.; Abrahami M.; Lilos P.; Phillip M.; Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel. Int J Obes 2005,29(6),571-578","journal-title":"Int J Obes"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3122\/jabfm.2010.04.090221","volume":"23","author":"Kong A.S.","year":"2010","unstructured":"Kong A.S.; Williams R.L.; Rhyne R.; Acanthosis Nigricans: High prevalence and association with diabetes in a practice-based research network consortium--a PRImary care Multi-Ethnic network (PRIME Net) study. J Am Board Fam Med 2010,23(4),476-485","journal-title":"J Am Board Fam Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4158\/EP.10.2.101","volume":"10","author":"Litonjua P.","year":"2004","unstructured":"Litonjua P.; Pi&#xF1;ero-Pilo&#xF1;a A.; Aviles-Santa L.; Raskin P.; Prevalence of Acanthosis nigricans in newly-diagnosed type 2 diabetes. Endocr Pract 2004,10(2),101-106","journal-title":"Endocr Pract"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2304746","DOI":"10.1155\/2018\/2304746","volume":"2018","author":"Sun H.","year":"2018","unstructured":"Sun H.; Wang X.; Chen J.; Melatonin treatment improves insulin resistance and pigmentation in obese patients with acanthosis nigri-cans. Int J Endocrinol 2018,2018,2304746","journal-title":"Int J Endocrinol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/jocd.13544","volume":"19","author":"Das A.","year":"2020","unstructured":"Das A.; Datta D.; Kassir M.; Acanthosis nigricans: A review. J Cosmet Dermatol 2020,19(8),1857-1865","journal-title":"J Cosmet Dermatol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"e240143","DOI":"10.1136\/bcr-2020-240143","volume":"14","author":"Maximiano C.","year":"2021","unstructured":"Maximiano C.; Silva M.R.; Gomes M.M.; Antunes A.; Singular case of acanthosis nigricans. BMJ Case Rep 2021,14(2),e240143","journal-title":"BMJ Case Rep"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4274\/jcrpe.4577","volume":"9","author":"Tuhan H.","year":"2017","unstructured":"Tuhan H.; Ceylaner S.; Nalbanto&#x11F;lu &#xD6;.; A mutation in INSR in a child presenting with severe acanthosis nigricans. J Clin Res Pediatr Endocrinol 2017,9(4),371-374","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"ref=18","author":"Maderal A.D.","year":"2022","unstructured":"Maderal A.D.;  Acanthosis nigricans UpToDate is a very popular electronic reference book Available from: 2022","journal-title":"Acanthosis nigricans UpToDate is a very popular electronic reference book"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1515\/jpem-2015-0384","volume":"29","author":"Krishnamurthy M.","year":"2016","unstructured":"Krishnamurthy M.; Pingul M.M.; A novel insulin receptor mutation in an adolescent with acanthosis nigricans and hyperandrogenism. J Pediatr Endocrinol Metab 2016,29(10),1201-1205","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jdcr.2019.10.023","volume":"6","author":"Alkeswani A.","year":"2020","unstructured":"Alkeswani A.; Pierce E.; Elmets C.A.; Idiopathic extensive acanthosis nigricans with a variant of the epidermal growth factor receptor. JAAD Case Rep 2020,6(2),79-82","journal-title":"JAAD Case Rep"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/jdv.13061","volume":"30","author":"Cossiez Cacard M.A.","year":"2016","unstructured":"Cossiez Cacard M.A.; Coulombe J.; Bernard P.; Familial hypochondroplasia and acanthosis nigricans with FGFR3 K650T mutation. J Eur Acad Dermatol Venereol 2016,30(5),897-898","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1297\/cpe.26.223","volume":"26","author":"Hirai H.","year":"2017","unstructured":"Hirai H.; Hamada J.; Hasegawa K.; Ishii E.; Acanthosis nigricans in a Japanese boy with hypochondroplasia due to a K650T mutation in FGFR3. Clin Pediatr Endocrinol 2017,26(4),223-228","journal-title":"Clin Pediatr Endocrinol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1658062","DOI":"10.1155\/2016\/1658062","volume":"2016","author":"Huang Y.","year":"2016","unstructured":"Huang Y.; Yang J.; Li Y.; FGF21 is associated with acanthosis nigricans in obese patients. Int J Endocrinol 2016,2016,1658062","journal-title":"Int J Endocrinol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/jdv.13580","volume":"30","author":"Ichiyama S.","year":"2016","unstructured":"Ichiyama S.; Funasaka Y.; Otsuka Y.; Effective treatment by glycolic acid peeling for cutaneous manifestation of familial generalized acanthosis nigricans caused by FGFR3 mutation. J Eur Acad Dermatol Venereol 2016,30(3),442-445","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1111\/1346-8138.13939","volume":"44","author":"Ichiyama S.","year":"2017","unstructured":"Ichiyama S.; Kubo A.; Matayoshi T.; Saeki H.; Funasaka Y.; Effects of glycolic acid peeling on the cutaneous manifestation of generalized acanthosis nigricans caused by FGFR3 mutation: A report of one sporadic and two familial cases. J Dermatol 2017,44(10),e250-e251","journal-title":"J Dermatol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"840492","DOI":"10.1155\/2014\/840492","volume":"2014","author":"Mustafa M.","year":"2014","unstructured":"Mustafa M.; Moghrabi N.; Bin-Abbas B.; Hypochondroplasia, acanthosis nigricans, and insulin resistance in a child with FGFR3 mutation: Is it just an association? Case Rep Endocrinol 2014,2014,840492","journal-title":"Case Rep Endocrinol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/ajmg.a.38141","volume":"173","author":"Couser N.L.","year":"2017","unstructured":"Couser N.L.; Pande C.K.; Turcott C.M.; Spector E.B.; Aylsworth A.S.; Powell C.M.; Mild achondroplasia\/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation. Am J Med Genet A 2017,173(4),1097-1101","journal-title":"Am J Med Genet A"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/jp.2013.139","volume":"34","author":"Herman T.E.","year":"2014","unstructured":"Herman T.E.; Sargar K.; Siegel M.J.; Crouzono-dermo-skeletal syndrome, Crouzon syndrome with acanthosis nigricans syndrome. J Perinatol 2014,34(2),164-165","journal-title":"J Perinatol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"e451","DOI":"10.1111\/1346-8138.15580","volume":"47","author":"Kariya H.","year":"2020","unstructured":"Kariya H.; Nakano H.; Ishii N.; Crouzon syndrome with acanthosis nigricans and prominent diffuse hyperpigmentation associated with gain-of-function A391E mutation in FGFR3 gene. J Dermatol 2020,47(12),e451-e452","journal-title":"J Dermatol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.pedneo.2019.09.008","volume":"60","author":"Lin W.D.","year":"2019","unstructured":"Lin W.D.; Tsai F.J.; Wang C.H.; Mild osteochondrodysplasia with acanthosis nigricans in a short-statured Taiwanese family due to the p.Lys650Gln mutation in FGFR3. Pediatr Neonatol 2019,60(6),686-688","journal-title":"Pediatr Neonatol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jamadermatol.2013.3019","volume":"149","author":"Mir A.","year":"2013","unstructured":"Mir A.; Wu T.; Orlow S.J.; Cutaneous features of Crouzon syndrome with acanthosis nigricans. JAMA Dermatol 2013,149(6),737-741","journal-title":"JAMA Dermatol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/pde.13748","volume":"36","author":"Muguet Guenot L.","year":"2019","unstructured":"Muguet Guenot L.; Aubert H.; Isidor B.; Acanthosis nigricans, hypochondroplasia, and FGFR3 mutations: Findings with five new patients, and a review of the literature. Pediatr Dermatol 2019,36(2),242-246","journal-title":"Pediatr Dermatol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"e656","DOI":"10.1002\/mgg3.656","volume":"7","author":"Rymer K.","year":"2019","unstructured":"Rymer K.; Shiang R.; Hsiung A.; Expanding the phenotype for the recurrent p.Ala391Glu variant in FGFR3: Beyond crouzon syn-drome and acanthosis nigricans. Mol Genet Genomic Med 2019,7(6),e656","journal-title":"Mol Genet Genomic Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1002\/ajmg.a.40506","volume":"176","author":"Smid C.J.","year":"2018","unstructured":"Smid C.J.; Modaff P.; Alade A.; Legare J.M.; Pauli R.M.; Acanthosis nigricans in achondroplasia. Am J Med Genet A 2018,176(12),2630-2636","journal-title":"Am J Med Genet A"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/1055665617723918","volume":"55","author":"Xu W.","year":"2018","unstructured":"Xu W.; McDonald-McGinn D.M.; Melchiorre A.J.; Zackai E.H.; Bartlett S.P.; Taylor J.A.; Crouzon with acanthosis nigricans and odontogenic tumors: A rare form of syndromic craniosynostosis. Cleft Palate Craniofac J 2018,55(2),296-300","journal-title":"Cleft Palate Craniofac J"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/1346-8138.14623","volume":"45","author":"Yasuda M.","year":"2018","unstructured":"Yasuda M.; Morimoto N.; Shimizu A.; Toyoshima T.; Yokoyama Y.; Ishikawa O.; Familial acanthosis nigricans with the FGFR3 mutation: Differences of pigmentation between male and female patients. J Dermatol 2018,45(11),1357-1361","journal-title":"J Dermatol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/2229-5178.137765","volume":"5","author":"Phiske M.M.","year":"2014","unstructured":"Phiske M.M.; An approach to acanthosis nigricans. Indian Dermatol Online J 2014,5(3),239-249","journal-title":"Indian Dermatol Online J"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1046\/j.1525-1470.2002.00013.x","volume":"19","author":"Hermanns-L&#xEA; T.","year":"2002","unstructured":"Hermanns-L&#xEA; T.; Hermanns J.F.; Pi&#xE9;rard G.E.; Juvenile acanthosis nigricans and insulin resistance. Pediatr Dermatol 2002,19(1),12-14","journal-title":"Pediatr Dermatol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1089\/met.2013.0145","volume":"12","author":"Ayaz T.","year":"2014","unstructured":"Ayaz T.; Baydur &#x15E;ahin S.; &#x15E;ahin O.Z.; Relation of Acanthosis nigricans to metabolic syndrome in overweight and obese women. Metab Syndr Relat Disord 2014,12(6),320-323","journal-title":"Metab Syndr Relat Disord"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.5223\/pghn.2016.19.4.251","volume":"19","author":"Koh Y.K.","year":"2016","unstructured":"Koh Y.K.; Lee J.H.; Kim E.Y.; Moon K.R.; Acanthosis nigricans as a clinical predictor of insulin resistance in obese children. Pediatr Gastroenterol Hepatol Nutr 2016,19(4),251-258","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/apa.15031","volume":"109","author":"Maguolo A.","year":"2020","unstructured":"Maguolo A.; Maffeis C.; Acanthosis nigricans in childhood: A cutaneous marker that should not be underestimated, especially in obese children. Acta Paediatr 2020,109(3),481-487","journal-title":"Acta Paediatr"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.6065\/apem.2019.24.2.99","volume":"24","author":"Videira-Silva A.","year":"2019","unstructured":"Videira-Silva A.; Albuquerque C.; Fonseca H.; Acanthosis nigricans as a clinical marker of insulin resistance among overweight adolescents. Ann Pediatr Endocrinol Metab 2019,24(2),99-103","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0020-7292(00)00282-4","volume":"71","author":"Lestringant G.G.","year":"2000","unstructured":"Lestringant G.G.; Bener A.; Frossard P.; Townsend A.; Association of Acanthosis nigricans with risk of diabetes mellitus and hormonal dis-turbances in females. Int J Gynaecol Obstet 2000,71(3),267-269","journal-title":"Int J Gynaecol Obstet"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"e13453","DOI":"10.1111\/ijcp.13453","volume":"74","author":"&#xC1;lvarez-Villalobos N.A.","year":"2020","unstructured":"&#xC1;lvarez-Villalobos N.A.; Rodr&#xED;guez-Guti&#xE9;rrez R.; Gonz&#xE1;lez-Saldivar G.; Acanthosis nigricans in middle-age adults: A highly prevalent and specific clinical sign of insulin resistance. Int J Clin Pract 2020,74(3),e13453","journal-title":"Int J Clin Pract"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/2249-4863.214961","volume":"6","author":"Bhagyanathan M.","year":"2017","unstructured":"Bhagyanathan M.; Dhayanithy D.; Parambath V.A.; Bijayraj R.; Acanthosis nigricans: A screening test for insulin resistance - An important risk factor for diabetes mellitus type-2. J Family Med Prim Care 2017,6(1),43-46","journal-title":"J Family Med Prim Care"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1159\/000512918","volume":"237","author":"Agrawal K.","year":"2021","unstructured":"Agrawal K.; Mathur R.; Purwar N.; Mathur S.K.; Mathur D.K.; Hyperandrogenism, insulin resistance, and acanthosis nigricans (HAIR-AN) syndrome reflects adipose tissue dysfunction (&#x201C;adiposopathy&#x201D; or &#x201C;sick fat&#x201D;) in Asian Indian girls. Dermatology 2021,237(5),797-805","journal-title":"Dermatology"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"193097","DOI":"10.1155\/2015\/193097","volume":"2015","author":"D&#xE9;djan A.H.","year":"2015","unstructured":"D&#xE9;djan A.H.; Chadli A.; El Aziz S.; Farouqi A.; Hyperandrogenism-insulin resistance-acanthosis nigricans syndrome. Case Rep Endocrinol 2015,2015,193097","journal-title":"Case Rep Endocrinol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"e231749","DOI":"10.1136\/bcr-2019-231749","volume":"13","author":"O\u2019Brien B.","year":"2020","unstructured":"O\u2019Brien B.; Dahiya R.; Kimble R.; Hyperandrogenism, insulin resistance and acanthosis nigricans (HAIR-AN syndrome): An extreme sub-phenotype of polycystic ovary syndrome. BMJ Case Rep 2020,13(4),e231749","journal-title":"BMJ Case Rep"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"637","DOI":"10.5021\/ad.2016.28.5.637","volume":"28","author":"Saito K.","year":"2016","unstructured":"Saito K.; Ando H.; Goto K.; A case of hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome; increase in proliferat-ing cell nuclear antigen and decrease in loricrin in acanthosis nigricans. Ann Dermatol 2016,28(5),637-639","journal-title":"Ann Dermatol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1056\/NEJMicm1508730","volume":"374","author":"Lauria M.W.","year":"2016","unstructured":"Lauria M.W.; Saad M.J.; Images in clinical medicine. Acanthosis nigricans and insulin resistance. N Engl J Med 2016,374(24),e31","journal-title":"N Engl J Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"e11330","DOI":"10.7759\/cureus.11330","volume":"12","author":"Rao G.","year":"2020","unstructured":"Rao G.; Chauhan Y.V.; Varthakavi P.K.; Bhagwat N.; A lean lady with acanthosis nigricans and uncontrolled diabetes mellitus. Cureus 2020,12(11),e11330","journal-title":"Cureus"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.3892\/ol.2018.9736","volume":"17","author":"Popa M.L.","year":"2019","unstructured":"Popa M.L.; Popa A.C.; Tanase C.; Gheorghisan-Galateanu A.A.; Acanthosis nigricans: To be or not to be afraid. Oncol Lett 2019,17(5),4133-4138","journal-title":"Oncol Lett"},{"key":"ref=53","first-page":"E20","volume":"105","author":"Bomar L.","year":"2020","unstructured":"Bomar L.; Lewallen R.; Jorizzo J.; Localized acanthosis nigricans at the site of repetitive insulin injections. Cutis 2020,105(2),E20-E22","journal-title":"Cutis"},{"key":"ref=54","first-page":"e85","volume":"11","author":"Brodell J.D.","year":"2012","unstructured":"Brodell J.D.; Cannella J.D.; Helms S.E.; Case report: Acanthosis nigricans resulting from repetitive same-site insulin injections. J Drugs Dermatol 2012,11(12),e85-e87","journal-title":"J Drugs Dermatol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1016\/j.diabres.2011.07.023","volume":"94","author":"Buz&#xE1;si K.","year":"2011","unstructured":"Buz&#xE1;si K.; S&#xE1;pi Z.; Jermendy G.; Acanthosis nigricans as a local cutaneous side effect of repeated human insulin injections. Diabetes Res Clin Pract 2011,94(2),e34-e36","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5070\/D34GD131PK","volume":"17","author":"Hartman R.","year":"2011","unstructured":"Hartman R.; Defelice T.; Tzu J.; Meehan S.; Sanchez M.; Acanthosis nigricans in the setting of niacin therapy. Dermatol Online J 2011,17(10),11","journal-title":"Dermatol Online J"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"E1390","DOI":"10.1503\/cmaj.180705","volume":"190","author":"Huang Y.","year":"2018","unstructured":"Huang Y.; Hessami-Booshehri M.; Acanthosis nigricans at sites of insulin injection in a man with diabetes. CMAJ 2018,190(47),E1390","journal-title":"CMAJ"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12879-020-05089-1","volume":"20","author":"Iacovelli A.","year":"2020","unstructured":"Iacovelli A.; Mezzaroma I.; Di Paolo M.; Soda G.; De Vincentiis L.; Palange P.; A case of acanthosis nigricans in a HIV-infected patient. BMC Infect Dis 2020,20(1),360","journal-title":"BMC Infect Dis"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1177\/0960327113514099","volume":"33","author":"Karadag A.","year":"2014","unstructured":"Karadag A.; Kavala M.; Demir F.; Turko&#x11F;lu Z.; Kartal I.; Zemheri E.; A case of hyperpigmentation and acanthosis nigricans by testosterone injections. Hum Exp Toxicol 2014,33(12),1297-1301","journal-title":"Hum Exp Toxicol"},{"key":"ref=60","first-page":"136","volume":"86","author":"Lee M.","year":"2010","unstructured":"Lee M.; Grassi M.; Acanthosis nigricans in a patient treated with palifermin. Cutis 2010,86(3),136-137","journal-title":"Cutis"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1097\/MJT.0b013e3182491e29","volume":"21","author":"Manu P.","year":"2014","unstructured":"Manu P.; Al-Dhaher Z.; Dargani N.; Correll C.U.; Acanthosis nigricans during treatment with aripiprazole. Am J Ther 2014,21(3),e90-e93","journal-title":"Am J Ther"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"e14794","DOI":"10.1111\/dth.14794","volume":"34","author":"Mourad A.I.","year":"2021","unstructured":"Mourad A.I.; Haber R.M.; Drug-induced acanthosis nigricans: A systematic review and new classification. Dermatol Ther 2021,34(2),e14794","journal-title":"Dermatol Ther"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jcjd.2019.08.010","volume":"44","author":"Pal R.","year":"2020","unstructured":"Pal R.; Bhattacharjee R.; Chatterjee D.; Bhadada S.K.; Bhansali A.; Dutta P.; Exogenous insulin-induced localized acanthosis nigricans: A rare injection site complication. Can J Diabetes 2020,44(3),219-221","journal-title":"Can J Diabetes"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"553","DOI":"10.4103\/0378-6323.113112","volume":"79","author":"Sawatkar G.U.","year":"2013","unstructured":"Sawatkar G.U.; Dogra S.; Bhadada S.K.; Kanwar A.J.; Acanthosis nigricans--an uncommon cutaneous adverse effect of a common medication: Report of two cases. Indian J Dermatol Venereol Leprol 2013,79(4),553","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/1346-8138.14107","volume":"45","author":"Fukuchi K.","year":"2018","unstructured":"Fukuchi K.; Tatsuno K.; Matsushita K.; Kubo A.; Ito T.; Tokura Y.; Familial acanthosis nigricans with p.K650T FGFR3 mutation. J Dermatol 2018,45(2),207-210","journal-title":"J Dermatol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1365-4362.1996.tb03278.x","volume":"35","author":"Dhar S.","year":"1996","unstructured":"Dhar S.; Dawn G.; Kanwar A.J.; Nada R.; Familial acanthosis nigricans. Int J Dermatol 1996,35(2),126-127","journal-title":"Int J Dermatol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s10038-021-00905-1","volume":"66","author":"Tahara U.","year":"2021","unstructured":"Tahara U.; Yasuda M.; Yamada Y.; Autosomal dominant familial acanthosis nigricans caused by a C-terminal nonsense mutation of FGFR3. J Hum Genet 2021,66(8),831-834","journal-title":"J Hum Genet"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/bjd.12293","volume":"169","author":"Ahmad S.","year":"2013","unstructured":"Ahmad S.; Mahmoudi H.; Naeem M.; Betz R.C.; Autosomal recessive isolated familial acanthosis nigricans in a Pakistani family due to a homozygous mutation in the insulin receptor gene. Br J Dermatol 2013,169(2),476-478","journal-title":"Br J Dermatol"},{"key":"ref=69","first-page":"161","volume":"8","author":"Kapoor S.","year":"2010","unstructured":"Kapoor S.; Diagnosis and treatment of Acanthosis nigricans. Skinmed 2010,8(3),161-164","journal-title":"Skinmed"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/pde.12932","volume":"33","author":"Kapoor S.","year":"2016","unstructured":"Kapoor S.; Lelis syndrome: A rare cause of acanthosis nigricans. Pediatr Dermatol 2016,33(5),563","journal-title":"Pediatr Dermatol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clindermatol.2017.09.008","volume":"36","author":"Karada&#x11F; A.S.","year":"2018","unstructured":"Karada&#x11F; A.S.; You Y.; Danarti R.; Al-Khuzaei S.; Chen W.; Acanthosis nigricans and the metabolic syndrome. Clin Dermatol 2018,36(1),48-53","journal-title":"Clin Dermatol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"arsr.2012.110017.","DOI":"10.1258\/arsr.2012.110017","volume":"1","author":"N&#xF8;rgaard P","year":"2012","unstructured":"N&#xF8;rgaard P; Hagen CP; Hove H; Dun&#xF8; M; Nissen KR; Kreiborg S; Crouzon syndrome associated with acanthosis nigricans: Prenatal 2D and 3D ultrasound findings and postnatal 3D CT findings. Acta Radiol Short Rep 2012,1(4),arsr.2012.110017.","journal-title":"Acta Radiol Short Rep"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4183\/aeb.2019.129","volume":"5","author":"Ozdemir Kutbay N.","year":"2019","unstructured":"Ozdemir Kutbay N.; Sarer Yurekli B.; Yasar Z.; Akinci B.; An unusual case of acquired partial lipodystrophy presenting with acanthosis nigricans. Acta Endocrinol (Buchar) 2019,5(1),129-130","journal-title":"Acta Endocrinol (Buchar)"},{"key":"ref=74","first-page":"363","volume":"23","author":"Zaridoust A.","year":"2013","unstructured":"Zaridoust A.; Rabbani A.; Sayarifard F.; Thiel C.T.; Rezaei N.; Acanthosis nigricans, abnormal facial appearance and dentition in an insulin resistance syndrome. Iran J Pediatr 2013,23(3),363-365","journal-title":"Iran J Pediatr"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/ans.15052","volume":"90","author":"Chatzopoulou D.","year":"2020","unstructured":"Chatzopoulou D.; Triantafyllou T.; Tsamis D.; Case presentation of acanthosis nigricans diagnosed with gastric adenocarcinoma. ANZ J Surg 2020,90(1-2),182-184","journal-title":"ANZ J Surg"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000456652","volume":"9","author":"Deen J.","year":"2017","unstructured":"Deen J.; Moloney T.; Burdon-Jones D.; Severe, Malignant acanthosis nigricans associated with adenocarcinoma of the endometrium in a young obese female. Case Rep Dermatol 2017,9(1),30-37","journal-title":"Case Rep Dermatol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1111\/jdv.14087","volume":"31","author":"Moreno-Artero E.","year":"2017","unstructured":"Moreno-Artero E.; Querol E.; Ivars M.; Sola I.; P&#xED;o R.; Espa&#xF1;a A.; Assessment of EGF receptor ligand expression in gastric carcinoma and in lesional skin of paraneoplastic acanthosis nigricans: A case report. J Eur Acad Dermatol Venereol 2017,31(6),e301-e302","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"S383","DOI":"10.22088\/cjim.12.0.383","volume":"12","author":"Mosannen Mozafari P.","year":"2021","unstructured":"Mosannen Mozafari P.; Salek R.; Taghizadeh A.; Yazdanpanah M.J.; Mosannen Mozaffari H.; Esmaeili E.; Diagnosis of an occult gastric ade-nocarcinoma by oral manifestations (acanthosis nigricans): A case report. Caspian J Intern Med 2021,12(Suppl. 2),S383-S387","journal-title":"Caspian J Intern Med"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jdcr.2019.10.003","volume":"5","author":"Nadelman D.A.","year":"2019","unstructured":"Nadelman D.A.; Orbuch D.; Sandigursky S.; Femia A.N.; Systemic sclerosis with malignant acanthosis nigricans in a patient with gastric ade-nocarcinoma. JAAD Case Rep 2019,5(12),1045-1047","journal-title":"JAAD Case Rep"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.amjms.2016.08.029","volume":"353","author":"Yin W.B.","year":"2017","unstructured":"Yin W.B.; Gao Y.; Lu Y.; Gastric cancer associated with malignant acanthosis nigricans. Am J Med Sci 2017,353(4),416","journal-title":"Am J Med Sci"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12957-017-1274-5","volume":"15","author":"Yu Q.","year":"2017","unstructured":"Yu Q.; Li X.L.; Ji G.; Malignant acanthosis nigricans: An early diagnostic clue for gastric adenocarcinoma. World J Surg Oncol 2017,15(1),208","journal-title":"World J Surg Oncol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/den.12679","volume":"28","author":"Amano T.","year":"2016","unstructured":"Amano T.; Nishida T.; Inada M.; Diffuse esophageal papillomatosis in a patient with acanthosis nigricans. Dig Endosc 2016,28(6),685","journal-title":"Dig Endosc"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1590\/abd1806-4841.20187560","volume":"93","author":"Antonio J.R.","year":"2018","unstructured":"Antonio J.R.; Tr&#xED;dico L.A.; Antonio C.R.; Malignant Acanthosis nigricans associated with early diagnosis of liver cancer. An Bras Dermatol 2018,93(4),616-617","journal-title":"An Bras Dermatol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijwd.2019.03.002","volume":"5","author":"Arellano J.","year":"2019","unstructured":"Arellano J.; Iglesias P.; Suarez C.; Corredoira Y.; Schnettler K.; Malignant acanthosis nigricans as a paraneoplastic manifestation of metastatic breast cancer. Int J Womens Dermatol 2019,5(3),183-186","journal-title":"Int J Womens Dermatol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"453","DOI":"10.4103\/idoj.IDOJ_427_18","volume":"10","author":"Barman B.","year":"2019","unstructured":"Barman B.; Devi L.P.; Thakur B.K.; Raphael V.; Tripe palms and acanthosis nigricans: A clue for diagnosis of advanced pancreatic adenocar-cinoma. Indian Dermatol Online J 2019,10(4),453-455","journal-title":"Indian Dermatol Online J"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4322\/acr.2016.021","volume":"6","author":"Ferraz de Campos F.P.","year":"2016","unstructured":"Ferraz de Campos F.P.; Narvaez M.R.; Reis P.V.; Acanthosis Nigricans associated with clear-cell renal cell carcinoma. Autops Case Rep 2016,6(1),33-40","journal-title":"Autops Case Rep"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"739","DOI":"10.4103\/2230-8210.139223","volume":"18","author":"Jyotsna V.P.","year":"2014","unstructured":"Jyotsna V.P.; Raizada N.; Chakraborty S.; Pal S.; Acanthosis nigricans in insulinoma. Indian J Endocrinol Metab 2014,18(5),739","journal-title":"Indian J Endocrinol Metab"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"4815","DOI":"10.2147\/OTT.S95020","volume":"9","author":"Karakas Y.","year":"2016","unstructured":"Karakas Y.; Esin E.; Lacin S.; Ceyhan K.; Heper A.O.; Yalcin S.; A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer. OncoTargets Ther 2016,9,4815-4820","journal-title":"OncoTargets Ther"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1111\/ajd.13409","volume":"62","author":"Kovitwanichkanont T.","year":"2021","unstructured":"Kovitwanichkanont T.; Prakash S.; Chong A.H.; Pancreatic adenocarcinoma presenting as subacute cutaneous lupus, tripe palms and acan-thosis nigricans maligna. Australas J Dermatol 2021,62(1),e132-e133","journal-title":"Australas J Dermatol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2490-14-88","volume":"14","author":"Kubicka-Wo\u0142kowska J.","year":"2014","unstructured":"Kubicka-Wo\u0142kowska J.; D\u0119bska-Szmich S.; Lisik-Habib M.; Noweta M.; Potemski P.; Malignant acanthosis nigricans associated with prostate cancer: A case report. BMC Urol 2014,14(1),88","journal-title":"BMC Urol"},{"key":"ref=91","first-page":"29","volume":"4","author":"Mascitti M.","year":"2013","unstructured":"Mascitti M.; Santarelli A.; Albanese A.; Campisi G.; Muzio L.L.; Paraneoplastic acanthosis nigricans maligna. Ann Stomatol (Roma) 2013,4(Suppl. 2),29","journal-title":"Ann Stomatol (Roma)"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3109\/0284186X.2014.998274","volume":"54","author":"Meng X.","year":"2015","unstructured":"Meng X.; Xie F.; Wang W.; Ba W.; Li C.; Florid cutaneous manifestations with acanthosis nigricans in a lung cancer patient. Acta Oncol 2015,54(8),1225-1226","journal-title":"Acta Oncol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3904\/kjim.2013.28.5.632","volume":"28","author":"Park K.W.","year":"2013","unstructured":"Park K.W.; Lim D.H.; Lee S.I.; Malignant acanthosis nigricans in a patient with a gastrointestinal stromal tumor. Korean J Intern Med (Korean Assoc Intern Med) 2013,28(5),632-633","journal-title":"Korean J Intern Med (Korean Assoc Intern Med)"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"bcr2016218003","DOI":"10.1136\/bcr-2016-218003","volume":"2016","author":"Patra S.","year":"2016","unstructured":"Patra S.; Chakraborty P.P.; Barman H.; Santra G.; Acanthosis nigricans in insulinoma: Before and after successful surgical enucleation. BMJ Case Rep 2016,2016,bcr2016218003","journal-title":"BMJ Case Rep"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.18502\/ijph.v50i7.6651","volume":"50","author":"Rahimi H.","year":"2021","unstructured":"Rahimi H.; Moravvej H.; Krukenberg tumor manifesting with hirsutism and acanthosis nigricans as the exclusive presenting symptoms. Iran J Public Health 2021,50(7),1504-1508","journal-title":"Iran J Public Health"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/2229-5178.110640","volume":"4","author":"Singh S.K.","year":"2013","unstructured":"Singh S.K.; Rai T.; A rare case of malignant acanthosis nigricans in a lady with ovarian cancer. Indian Dermatol Online J 2013,4(2),125-127","journal-title":"Indian Dermatol Online J"},{"key":"ref=97","first-page":"578","volume":"151","author":"Tammaro A.","year":"2016","unstructured":"Tammaro A.; Giulianelli V.; Parisella F.; Persechino S.; Bilaterally mammary acanthosis nigricans as paraneoplastic manifestation of prostate adenocarcinoma. G Ital Dermatol Venereol 2016,151(5),578-579","journal-title":"G Ital Dermatol Venereol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12886-020-01708-2","volume":"20","author":"Zhang X.","year":"2020","unstructured":"Zhang X.; Liu R.; Liu Y.; Zhang S.; Qi H.; Malignant acanthosis nigricans: A case report. BMC Ophthalmol 2020,20(1),446","journal-title":"BMC Ophthalmol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2147\/OTT.S290124","volume":"14","author":"Zhang R.","year":"2021","unstructured":"Zhang R.; Jiang M.; Lei W.; Wang A.; Malignant acanthosis nigricans with recurrent bladder cancer: A case report and review of literature. OncoTargets Ther 2021,14,951-957","journal-title":"OncoTargets Ther"},{"key":"ref=100","first-page":"493","volume":"16","author":"Behrangi E.","year":"2013","unstructured":"Behrangi E.; Rahmanifar H.; Rabani R.; Kajbafi M.; Acanthosis nigricans. Arch Iran Med 2013,16(8),493-494","journal-title":"Arch Iran Med"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jpeds.2017.12.014","volume":"195","author":"Leung A.K.C.","year":"2018","unstructured":"Leung A.K.C.; Barankin B.; Lam J.M.; Terra firma-forme dermatosis. J Pediatr 2018,195,302-302.e1","journal-title":"J Pediatr"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"309","DOI":"10.25270\/con.2018.11.00001","volume":"58","author":"Leung A.K.C.","year":"2018","unstructured":"Leung A.K.C.; Barankin B.; Leung A.A.; Lam J.M.; A hyperpigmented patch that remains despite washing with soap and water: Terra firma-forme dermatosis. Consultant 2018,58(11),309-315","journal-title":"Consultant"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/postgradmedj-2019-136834","volume":"96","author":"Marchand L.","year":"2020","unstructured":"Marchand L.; Gaimard M.; Luyton C.; All about skin manifestations of insulin resistance and type 2 diabetes: Acanthosis nigricans and acrochordons. Postgrad Med J 2020,96(1134),237","journal-title":"Postgrad Med J"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1590\/S0365-05962012000100012","volume":"87","author":"Barbato M.T.","year":"2012","unstructured":"Barbato M.T.; Criado P.R.; Silva A.K.; Averbeck E.; Guerine M.B.; S&#xE1; N.B.; Association of acanthosis nigricans and skin tags with insulin re-sistance. An Bras Dermatol 2012,87(1),97-104","journal-title":"An Bras Dermatol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/ijd.IJD_646_18","volume":"65","author":"Singh S.K.","year":"2020","unstructured":"Singh S.K.; Agrawal N.K.; Vishwakarma A.K.; Association of acanthosis nigricans and acrochordon with insulin resistance: A cross-sectional hospital-based study from North India. Indian J Dermatol 2020,65(2),112-117","journal-title":"Indian J Dermatol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2340\/00015555-0906","volume":"91","author":"Barabash-Neila R.","year":"2011","unstructured":"Barabash-Neila R.; Freire L.R.; Zulueta-Dorado T.; Conejo-Mir J.; Thickening of the skin on the forehead: A quiz. Acanthosis nigricans with forehead location. Acta Derm Venereol 2011,91(1),108","journal-title":"Acta Derm Venereol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/j.1346-8138.2011.01252.x","volume":"38","author":"Chrysomali E.","year":"2011","unstructured":"Chrysomali E.; Piperi E.; Sklavounou-Andrikopoulou A.; Oral acanthosis nigricans in chronic hepatitis B with a 21-year follow up. J Dermatol 2011,38(12),1172-1176","journal-title":"J Dermatol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"e1471958","DOI":"10.1080\/19381980.2018.1471958","volume":"10","author":"Gonz&#xE1;lez-Saldivar G.","year":"2018","unstructured":"Gonz&#xE1;lez-Saldivar G.; Rodr&#xED;guez-Guti&#xE9;rrez R.; Trevi&#xF1;o-Alvarez A.M.; Acanthosis nigricans in the knuckles: An early, accessible, straightforward, and sensitive clinical tool to predict insulin resistance. Dermatoendocrinol 2018,10(1),e1471958","journal-title":"Dermatoendocrinol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1111\/pde.12806","volume":"33","author":"Guffey D.","year":"2016","unstructured":"Guffey D.; Narahari S.; Alinia H.; Hyperpigmented plaques of the alar crease: An unusual presentation of acanthosis nigricans. Pediatr Dermatol 2016,33(2),e160-e161","journal-title":"Pediatr Dermatol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/ICO.0000000000002513","volume":"40","author":"Huang N.","year":"2021","unstructured":"Huang N.; Yin H.Y.; Swan R.; Paraneoplastic conjunctival acanthosis nigricans: A case report. Cornea 2021,40(3),377-379","journal-title":"Cornea"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4103\/0019-5154.160540","volume":"60","author":"Kura M.M.","year":"2015","unstructured":"Kura M.M.; Sanghavi S.A.; Acral acanthosis nigricans in a case of scleroderma. Indian J Dermatol 2015,60(4),423","journal-title":"Indian J Dermatol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"463","DOI":"10.5021\/ad.2010.22.4.463","volume":"22","author":"Lee Y.B.","year":"2010","unstructured":"Lee Y.B.; Lee J.D.; Cho S.H.; Unusual presentation of obesity-associated dermatoses: Acanthosis nigricans involving both auricles. Ann Dermatol 2010,22(4),463-464","journal-title":"Ann Dermatol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"290","DOI":"10.12809\/hkmj134071","volume":"20","author":"Ng H.Y.","year":"2014","unstructured":"Ng H.Y.; Young J.H.; Huen K.F.; Chan L.T.; Acanthosis nigricans in obese Chinese children. Hong Kong Med J 2014,20(4),290-296","journal-title":"Hong Kong Med J"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/AHMT.S103396","volume":"8","author":"Ng H.Y.","year":"2016","unstructured":"Ng H.Y.; Acanthosis nigricans in obese adolescents: Prevalence, impact, and management challenges. Adolesc Health Med Ther 2016,8,1-10","journal-title":"Adolesc Health Med Ther"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/pde.13989","volume":"36","author":"Nolan C.F.","year":"2019","unstructured":"Nolan C.F.; Brelsford M.A.; The metabolic salute: A unique presentation of transverse nasal acanthosis nigricans and allergic rhinitis in an obese pediatric patient. Pediatr Dermatol 2019,36(6),973-974","journal-title":"Pediatr Dermatol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.jpeds.2015.08.046","volume":"167","author":"Ozhan B.","year":"2015","unstructured":"Ozhan B.; Yilmaz Agladioglu S.; Yuksel S.; Sanli B.; Perioral Acanthosis nigricans. J Pediatr 2015,167(6),1453","journal-title":"J Pediatr"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4103\/ijd.IJD_545_17","volume":"62","author":"Panda S.","year":"2017","unstructured":"Panda S.; Das A.; Lahiri K.; Facial acanthosis nigricans: A morphological marker of metabolic syndrome. Indian J Dermatol 2017,62(6),591-597","journal-title":"Indian J Dermatol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.4103\/2230-8210.103048","volume":"16","author":"Roy N.","year":"2012","unstructured":"Roy N.; Das T.; Kundu A.K.; Maity A.; Atypical presentation of acanthosis nigricans. Indian J Endocrinol Metab 2012,16(6),1058-1059","journal-title":"Indian J Endocrinol Metab"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/1346-8138.13559","volume":"44","author":"Woo Y.R.","year":"2017","unstructured":"Woo Y.R.; Lim J.H.; Kim M.; Park H.J.; Linear acanthosis nigricans on the anterior neck: Koebner phenomenon observed in a patient with acanthosis nigricans. J Dermatol 2017,44(7),843-845","journal-title":"J Dermatol"},{"key":"ref=120","first-page":"40","volume":"7","author":"Deklotz C.M.","year":"2014","unstructured":"Deklotz C.M.; Eshagh K.; Krakowski A.C.; Psoriatic plaques &#x201C;koebnerizing&#x201D; to areas of acanthosis nigricans in an obese female: Clues to a common pathway? J Clin Aesthet Dermatol 2014,7(11),40-41","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"95","DOI":"10.5021\/ad.2011.23.1.95","volume":"23","author":"Jeong J.S.","year":"2011","unstructured":"Jeong J.S.; Lee J.Y.; Yoon T.Y.; Unilateral nevoid acanthosis nigricans with a submammary location. Ann Dermatol 2011,23(1),95-97","journal-title":"Ann Dermatol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/bjd.17095","volume":"180","author":"Larsabal M.","year":"2019","unstructured":"Larsabal M.; Cogrel O.; Caumont C.; Jegou M.H.; Ta&#xEF;eb A.; Morice-Picard F.; Mosaic mutations in FGFR3 and FGFR2 are associated with nae-void acanthosis nigricans or RAVEN (round and velvety epidermal naevus). Br J Dermatol 2019,180(1),201-202","journal-title":"Br J Dermatol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4103\/0378-6323.72460","volume":"76","author":"Krishnaram A.S.","year":"2010","unstructured":"Krishnaram A.S.; Unilateral nevoid acanthosis nigricans and neurofibromatosis 1: An unusual association. Indian J Dermatol Venereol Leprol 2010,76(6),715-717","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"bcr2015210614","DOI":"10.1136\/bcr-2015-210614","volume":"2015","author":"Bansal M.","year":"2015","unstructured":"Bansal M.; Yadav J.; Bansal A.; Unilateral nevoid acanthosis nigricans. BMJ Case Rep 2015,2015,bcr2015210614","journal-title":"BMJ Case Rep"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/ijd.IJD_127_19","volume":"65","author":"&#xC7;etinarslan T.","year":"2020","unstructured":"&#xC7;etinarslan T.; G&#xFC;nd&#xFC;z K.; Temiz P.; Periumbilical acanthosis nigricans along the surgical site of umbilical hernia operation. Indian J Dermatol 2020,65(1),70-72","journal-title":"Indian J Dermatol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"660","DOI":"10.4103\/ijdvl.IJDVL_1016_18","volume":"87","author":"Reyes-Meza S.E.","year":"2021","unstructured":"Reyes-Meza S.E.; Guevara-Guti&#xE9;rrez E.; Villanueva-Quintero G.; Hern&#xE1;ndez-Arana S.; Tlacuilo-Parra A.; Nevoid acanthosis nigricans: Report of four cases localized to the umbilicus. Indian J Dermatol Venereol Leprol 2021,87(5),660-665","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.4103\/2229-5178.146201","volume":"5","author":"Anand V.","year":"2014","unstructured":"Anand V.; Das A.; Kumar P.; Kumar R.; Hassan S.; Acral acanthosis nigricans (acral acanthotic anomaly). Indian Dermatol Online J 2014,5(6)(Suppl. 2),S140-S141","journal-title":"Indian Dermatol Online J"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/1203475417736282","volume":"22","author":"Bishnoi A.","year":"2018","unstructured":"Bishnoi A.; Parsad D.; Velvety hyperpigmentation on hands and feet of a young girl: Acral acanthosis nigricans. J Cutan Med Surg 2018,22(3),323","journal-title":"J Cutan Med Surg"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-0034-1387732","volume":"123","author":"G&#xF3;mez-Flores M.","year":"2015","unstructured":"G&#xF3;mez-Flores M.; Gonz&#xE1;lez-Saldivar G.; Santos-Santos O.; Implications of a clinically ignored site of acanthosis nigricans: The knuckles. Exp Clin Endocrinol Diabetes 2015,123(1),27-33","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s13300-019-00703-1","volume":"10","author":"Rodr&#xED;guez-Guti&#xE9;rrez R","year":"2019","unstructured":"Rodr&#xED;guez-Guti&#xE9;rrez R; de la O-Cavazos ME; Salcido-Montenegro A; Acanthosis Nigricans in the Knuckles of Infants: A novel clini-cal marker of high metabolic risk. Diabetes Ther 2019,10(6),2169-2181","journal-title":"Diabetes Ther"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4103\/2229-5178.193898","volume":"7","author":"Verma S.","year":"2016","unstructured":"Verma S.; Vasani R.; Joshi R.; Phiske M.; Punjabi P.; Toprani T.; A descriptive study of facial acanthosis nigricans and its association with body mass index, waist circumference and insulin resistance using HOMA2 IR. Indian Dermatol Online J 2016,7(6),498-503","journal-title":"Indian Dermatol Online J"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.4103\/2229-5178.146184","volume":"5","author":"Das D.","year":"2014","unstructured":"Das D.; Das A.; Kumar D.; Gharami R.C.; Generalized benign acanthosis nigricans in an infant. Indian Dermatol Online J 2014,5(6)(Suppl. 2),S116-S118","journal-title":"Indian Dermatol Online J"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1442-200X.2009.02875.x","volume":"51","author":"G&#xF6;n&#xFC;l M.","year":"2009","unstructured":"G&#xF6;n&#xFC;l M.; Kili&#xE7; A.; Cakmak S.K.; G&#xFC;l U.; Ekiz O.D.; Erg&#xFC;l G.; Juvenile generalized acanthosis nigricans without any systemic disease. Pediatr Int 2009,51(4),595-597","journal-title":"Pediatr Int"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"19614","DOI":"10.5070\/D3199019614","volume":"19","author":"Denadai R.","year":"2013","unstructured":"Denadai R.; Souto R.M.; Auada-Souto M.P.; Generalized acanthosis nigricans without systemic disease associated. Dermatol Online J 2013,19(9),19614","journal-title":"Dermatol Online J"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"375","DOI":"10.5021\/ad.2013.25.3.375","volume":"25","author":"Piccolo V.","year":"2013","unstructured":"Piccolo V.; Russo T.; Picciocchi R.; Errico M.; Ametrano O.; Moscarella E.; Generalized idiopathic benign acanthosis nigricans in childhood. Ann Dermatol 2013,25(3),375-377","journal-title":"Ann Dermatol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2340\/00015555-1759","volume":"94","author":"Iwade M.","year":"2014","unstructured":"Iwade M.; Ogawa E.; Koga H.; Generalised acanthosis nigricans in childhood with short stature associated with poor response to growth hormone provocation. Acta Derm Venereol 2014,94(4),486-487","journal-title":"Acta Derm Venereol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000337751","volume":"4","author":"Kondo Y.","year":"2012","unstructured":"Kondo Y.; Umegaki N.; Terao M.; Murota H.; Kimura T.; Katayama I.; A case of generalized acanthosis nigricans with positive lupus erythe-matosus-related autoantibodies and antimicrosomal antibody: Autoimmune acanthosis nigricans? Case Rep Dermatol 2012,4(1),85-91","journal-title":"Case Rep Dermatol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/jamadermatol.2019.1127","volume":"155","author":"Valejo Coelho M.M.","year":"2019","unstructured":"Valejo Coelho M.M.; Prokop J.; Fernandes C.; Acanthosis nigricans maligna. JAMA Dermatol 2019,155(9),1069","journal-title":"JAMA Dermatol"},{"key":"ref=139","first-page":"229","volume":"19","author":"Ahmed C.O.","year":"2021","unstructured":"Ahmed C.O.; Gomes M.K.; de Azevedo T.P.; Cuzzi T.; Ramos-E-Silva M.; Paraneoplastic dermatoses in breast cancer: Malignant acanthosis nigricans with tripe palm. Skinmed 2021,19(3),229-231","journal-title":"Skinmed"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1159\/000511251","volume":"14","author":"Chantarojanasiri T.","year":"2020","unstructured":"Chantarojanasiri T.; Buranathawornsom A.; Sirinawasatien A.; diffuse esophageal squamous papillomatosis: A rare disease associated with acanthosis nigricans and tripe palms. Case Rep Gastroenterol 2020,14(3),702-706","journal-title":"Case Rep Gastroenterol"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1590\/S0365-05962012000300030","volume":"87","author":"Costa M.C.","year":"2012","unstructured":"Costa M.C.; Martinez N.S.; Belicha M.G.; Leal F.; Acanthosis nigricans and &#x201C;tripe palm&#x201D; as paraneoplastic manifestations of metastatic tumor. An Bras Dermatol 2012,87(3),498-500","journal-title":"An Bras Dermatol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jdcr.2015.11.008","volume":"2","author":"Danesh M.J.","year":"2016","unstructured":"Danesh M.J.; Saylor D.K.; Leard L.E.; North J.P.; Fox L.P.; Acquired acanthosis nigricans with tripe palms in a patient with interstitial lung dis-ease. JAAD Case Rep 2016,2(1),59-62","journal-title":"JAAD Case Rep"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5070\/D37BH1H290","volume":"18","author":"Fabroni C.","year":"2012","unstructured":"Fabroni C.; Gimma A.; Cardinali C.; Lo Scocco G.; Tripe palms associated with malignant acanthosis nigricans in a patient with gastric ade-nocarcinoma: A case report and review of the literature. Dermatol Online J 2012,18(11),15","journal-title":"Dermatol Online J"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"e1307","DOI":"10.1002\/cnr2.1307","volume":"4","author":"Kumar P.","year":"2021","unstructured":"Kumar P.; Mukundan M.K.; Sehrawat A.; Sundriyal D.; Tripe palms and Malignant Acanthosis Nigricans: More than a diagnostic pointer. Cancer Rep (Hoboken) 2021,4(1),e1307","journal-title":"Cancer Rep (Hoboken)"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/jamadermatol.2015.2139","volume":"151","author":"Lee H.C.","year":"2015","unstructured":"Lee H.C.; Ker K.J.; Chong W.S.; Oral malignant acanthosis nigricans and tripe palms associated with renal urothelial carcinoma. JAMA Dermatol 2015,151(12),1381-1383","journal-title":"JAMA Dermatol"},{"key":"ref=146","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14995","author":"Liu Y.","year":"2021","unstructured":"Liu Y.; Xu X.; Yang Y.; Hu H.; Jiang X.; Xiong X.; Malignant acanthosis nigricans and diseases with extensive oral papillary hyperplas-ia. Clin Exp Dermatol 2021","journal-title":"Clin Exp Dermatol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-4632.2011.04915.x","volume":"52","author":"Murao K.","year":"2013","unstructured":"Murao K.; Sadamoto Y.; Kubo Y.; Arase S.; Generalized malignant acanthosis nigricans with &#x201C;deck-chair sign&#x201D;. Int J Dermatol 2013,52(3),377-378","journal-title":"Int J Dermatol"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1111\/ijd.12096","volume":"54","author":"Onajin O.","year":"2015","unstructured":"Onajin O.; Comfere N.I.; Co-occurrence of malignant acanthosis nigricans and the Leser-Tr&#xE9;lat sign in a patient with hepatocellular carcino-ma. Int J Dermatol 2015,54(5),e146-e148","journal-title":"Int J Dermatol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"888","DOI":"10.29271\/jcpsp.2019.09.888","volume":"29","author":"Rizwan M.","year":"2019","unstructured":"Rizwan M.; Iftikhar N.; Sarfraz T.; Ullah O.; Malignant acanthosis nigricans: An indicator of internal malignancy. J Coll Physicians Surg Pak 2019,29(9),888-890","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1200\/JCO.2012.42.5454","volume":"30","author":"Schulmann K.","year":"2012","unstructured":"Schulmann K.; Strate K.; Pox C.P.; Wieland U.; Kreuter A.; Paraneoplastic acanthosis nigricans with cutaneous and mucosal papillomatosis preceding recurrence of a gastric adenocarcinoma. J Clin Oncol 2012,30(32),e325-e326","journal-title":"J Clin Oncol"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5114\/pdia.2014.40663","volume":"31","author":"Stawczyk-Macieja M.","year":"2014","unstructured":"Stawczyk-Macieja M.; Szczerkowska-Dobosz A.; Nowicki R.; Majewska H.; Dubowik M.; Soko\u0142owska-Wojdy\u0142o M.; Malignant acanthosis nigricans, florid cutaneous papillomatosis and tripe palms syndrome associated with gastric adenocarcinoma. Postepy Dermatol Alergol 2014,31(1),56-58","journal-title":"Postepy Dermatol Alergol"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.adengl.2015.04.017","volume":"106","author":"Vilas-Sueiro A.","year":"2015","unstructured":"Vilas-Sueiro A.; Su&#xE1;rez-Amor &#xD3;.; Monteagudo B.; de Las Heras C.; Malignant acanthosis nigricans, florid cutaneous and mucosal papilloma-tosis, and tripe palms in a man with gastric adenocarcinoma. Actas Dermosifiliogr 2015,106(5),438-439","journal-title":"Actas Dermosifiliogr"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1111\/bjd.15396","volume":"176","author":"Wang L.","year":"2017","unstructured":"Wang L.; Long H.; Wen H.; Liu Z.; Ling T.; Image gallery: Generalized mucosal and cutaneous papillomatosis, a unique sign of malignant acanthosis nigricans. Br J Dermatol 2017,176(5),e99","journal-title":"Br J Dermatol"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.12998\/wjcc.v8.i22.5632","volume":"8","author":"Wang N.","year":"2020","unstructured":"Wang N.; Yu P.J.; Liu Z.L.; Zhu S.M.; Zhang C.W.; Malignant acanthosis nigricans with Leser-Tr&#xE9;lat sign and tripe palms: A case report. World J Clin Cases 2020,8(22),5632-5638","journal-title":"World J Clin Cases"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/ijd.12034","volume":"54","author":"Zhang N.","year":"2015","unstructured":"Zhang N.; Qian Y.; Feng A.P.; Acanthosis nigricans, tripe palms, and sign of Leser-Tr&#xE9;lat in a patient with gastric adenocarcinoma: Case report and literature review in China. Int J Dermatol 2015,54(3),338-342","journal-title":"Int J Dermatol"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ijos.2014.1","volume":"6","author":"Chu H.W.","year":"2014","unstructured":"Chu H.W.; Li J.M.; Chen G.F.; Ma J.Y.; Oral malignant acanthosis nigricans associated with endometrial adenocarcinoma. Int J Oral Sci 2014,6(4),247-249","journal-title":"Int J Oral Sci"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1111\/jocd.13670","volume":"19","author":"Elmas &#xD6;.F.","year":"2020","unstructured":"Elmas &#xD6;.F.; Demirba&#x15F; A.; Kutlu &#xD6;.; Kilit&#xE7;i A.; Atasoy M.; Utility of dermatoscopy in the diagnosis of acanthosis nigricans. J Cosmet Dermatol 2020,19(12),3426-3427","journal-title":"J Cosmet Dermatol"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"e14521","DOI":"10.1111\/dth.14521","volume":"33","author":"Pardeshi S.S.","year":"2020","unstructured":"Pardeshi S.S.; Khemani U.N.; Kamath R.R.; Kura M.M.; Jafferany M.; Therapeutic implications of dermoscopic findings in acanthosis nigricans: A clinical and histopathological study. Dermatol Ther 2020,33(6),e14521","journal-title":"Dermatol Ther"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"SC05","DOI":"10.7860\/JCDR\/2017\/24902.10203","volume":"11","author":"Sayarifard F.","year":"2017","unstructured":"Sayarifard F.; Sayarifard A.; Allahverdi B.; Ipakchi S.; Moghtaderi M.; Yaghmaei B.; Prevalence of acanthosis nigricans and related factors in Iranian obese children. J Clin Diagn Res 2017,11(7),SC05-SC07","journal-title":"J Clin Diagn Res"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"218","DOI":"10.5021\/ad.2012.24.2.218","volume":"24","author":"Berk D.R.","year":"2012","unstructured":"Berk D.R.; Acanthosis nigricans of the ears or terra firma-forme dermatosis? Ann Dermatol 2012,24(2),218-219","journal-title":"Ann Dermatol"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jpeds.2020.07.083","volume":"227","author":"Bhanja D.B.","year":"2020","unstructured":"Bhanja D.B.; Sil A.; Biswas S.K.; Idiopathic eruptive macular pigmentation. J Pediatr 2020,227,314","journal-title":"J Pediatr"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"archdischild-2021-322030","DOI":"10.1136\/archdischild-2021-322030","author":"Bossini B","year":"2021","unstructured":"Bossini B; Mazzolai M; Berti I; Barbi E; Hyperpigmented pityriasis versicolor misdiagnosed as acanthosis nigricans. Arch Dis Child 2021,archdischild-2021-322030","journal-title":"Arch Dis Child"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"13030\/qt3sw2t3b8","DOI":"10.5070\/D3217028120","volume":"21","author":"Cheng E","year":"2015","unstructured":"Cheng E; Roy DB; Magro CM; A case of acanthosis nigricans coexisting with mycosis fungoides. Dermatol Online J 2015,21(7),13030\/qt3sw2t3b8","journal-title":"Dermatol Online J"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1097\/DAD.0000000000000885","volume":"39","author":"Demirci G.T.","year":"2017","unstructured":"Demirci G.T.; Mansur A.T.; Demiralay E.; Terra firma-forme dermatosis misdiagnosed as nevoid acanthosis nigricans. Am J Dermatopathol 2017,39(10),782-784","journal-title":"Am J Dermatopathol"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"e10733","DOI":"10.7759\/cureus.10733","volume":"12","author":"Forouzan P.","year":"2020","unstructured":"Forouzan P.; Cohen P.R.; Erythrasma revisited: Diagnosis, differential diagnoses, and comprehensive review of treatment. Cureus 2020,12(9),e10733","journal-title":"Cureus"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/1346-8138.13819","volume":"44","author":"Fukumoto T.","year":"2017","unstructured":"Fukumoto T.; Kozaru T.; Sakaguchi M.; Oka M.; Concomitant confluent and reticulated papillomatosis and acanthosis nigricans in an obese girl with insulin resistance successfully treated with oral minocycline: Case report and published work review. J Dermatol 2017,44(8),954-958","journal-title":"J Dermatol"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1159\/000515735","volume":"13","author":"Guertler A.","year":"2021","unstructured":"Guertler A.; Evenschor N.; Seegraeber M.; Lichen planus pigmentosus inversus: A rare subvariant of lichen planus pigmentosus. Case Rep Dermatol 2021,13(2),407-410","journal-title":"Case Rep Dermatol"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4103\/0378-6323.69095","volume":"76","author":"Joshi R.","year":"2010","unstructured":"Joshi R.; Palwade P.K.; Idiopathic eruptive macular pigmentation or acanthosis nigricans? Indian J Dermatol Venereol Leprol 2010,76(5),591","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5826\/dpc.0403a17","volume":"4","author":"Kaminska-Winciorek G.","year":"2014","unstructured":"Kaminska-Winciorek G.; Wydmanski J.; Scope A.; Argenziano G.; Zalaudek I.; &#x201C;Neglected nipples&#x201D;: Acanthosis nigricans-like plaques caused by avoidance of nipple cleansing. Dermatol Pract Concept 2014,4(3),81-84","journal-title":"Dermatol Pract Concept"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jdcr.2021.08.032","volume":"16","author":"Kim D.J.","year":"2021","unstructured":"Kim D.J.; Truong S.V.; Paik A.; A case of acanthosis nigricans-like mycosis fungoides. JAAD Case Rep 2021,16,144-148","journal-title":"JAAD Case Rep"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"21","DOI":"10.25270\/cfp.2016.01.00001","volume":"15","author":"Leung A.K.C.","year":"2016","unstructured":"Leung A.K.C.; Barankin B.; Skin lesions erupt across a teenager\u2019s upper back: Confluent and reticulated papillomatosis. Consultant 2016,15,21-23","journal-title":"Consultant"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/cup.12581","volume":"42","author":"Park Y.J.","year":"2015","unstructured":"Park Y.J.; Kang H.Y.; Lee E.S.; Kim Y.C.; Differentiating confluent and reticulated papillomatosis from acanthosis nigricans. J Cutan Pathol 2015,42(12),944-952","journal-title":"J Cutan Pathol"},{"key":"ref=173","author":"Rice A.S.","year":"2021 Jan-Aug.","unstructured":"Rice A.S.; Cook C.;  In: StatPearls [Internet] Treasure Island (FL): 2021 Jan-Aug.","journal-title":"In: StatPearls [Internet] Treasure Island (FL):"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"E1535","DOI":"10.1503\/cmaj.210310","volume":"193","author":"Riquelme I.L.","year":"2021","unstructured":"Riquelme I.L.; Moyano E.G.; Axillary and inguinal erythrasma. CMAJ 2021,193(39),E1535","journal-title":"CMAJ"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"e14102","DOI":"10.1111\/dth.14102","volume":"33","author":"Verma S.B.","year":"2020","unstructured":"Verma S.B.; Wollina U.; Acne keloidalis nuchae with acanthosis nigricans of the neck: The pivotal role of the dermatologist in the early diagnosis of insulin resistance\u2019. Dermatol Ther 2020,33(6),e14102","journal-title":"Dermatol Ther"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/00000372-198508000-00010","volume":"7","author":"Willemze R.","year":"1985","unstructured":"Willemze R.; Scheffer E.; Van Vloten W.A.; Mycosis fungoides simulating acanthosis nigricans. Am J Dermatopathol 1985,7(4),367-371","journal-title":"Am J Dermatopathol"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12519-009-0004-7","volume":"5","author":"Ice C.L.","year":"2009","unstructured":"Ice C.L.; Murphy E.; Minor V.E.; Neal W.A.; Metabolic syndrome in fifth grade children with acanthosis nigricans: Results from the CARDI-AC project. World J Pediatr 2009,5(1),23-30","journal-title":"World J Pediatr"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1590\/1984-0462\/;2018;36;3;00017","volume":"36","author":"Palhares H.M.D.C.","year":"2018","unstructured":"Palhares H.M.D.C.; Zaidan P.C.; Dib F.C.M.; Silva A.P.D.; Resende D.C.S.; Borges M.F.; Association between acanthosis nigricans and other cardi-ometabolic risk factors in children and adolescents with overweight and obesity. Rev Paul Pediatr 2018,36(3),301-308","journal-title":"Rev Paul Pediatr"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1515\/jpem-2020-0154","volume":"33","author":"Daye M.","year":"2020","unstructured":"Daye M.; Selver Eklioglu B.; Atabek M.E.; Relationship of acanthosis nigricans with metabolic syndrome in obese children. J Pediatr Endocrinol Metab 2020,33(12),1563-1568","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12098-019-03080-6","volume":"87","author":"Thiagarajan S.","year":"2020","unstructured":"Thiagarajan S.; Arun Babu T.; Manivel P.; Acanthosis nigricans and metabolic risk factors in obese children. Indian J Pediatr 2020,87(2),162","journal-title":"Indian J Pediatr"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.3889\/oamjms.2019.258","volume":"7","author":"Wollina U.","year":"2019","unstructured":"Wollina U.; Hansel G.; Lotti T.; Tchernev G.; Vojvodic A.; Temelkova I.; Acanthosis nigricans - A two-sided coin: Consider metabolic syn-drome and malignancies! Open Access Maced J Med Sci 2019,7(18),3081-3084","journal-title":"Open Access Maced J Med Sci"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.2337\/dc07-2108","volume":"31","author":"Daitchman J.","year":"2008","unstructured":"Daitchman J.; Vermeulen M.J.; Ray J.G.; Acanthosis nigricans among women with gestational diabetes mellitus and risk of adverse pregnancy outcomes. Diabetes Care 2008,31(5),e30","journal-title":"Diabetes Care"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"10999","DOI":"10.26355\/eurrev_202011_23584","volume":"24","author":"&#xD6;zhan B.","year":"2020","unstructured":"&#xD6;zhan B.; As\u0131lt&#xFC;rk H.; Y&#xFC;ksel S.; Acanthosis nigricans: A warning sign of lower urinary tract dysfunction in obese children? Eur Rev Med Pharmacol Sci 2020,24(21),10999-11005","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4274\/jcrpe.1515","volume":"7","author":"Pirgon &#xD6;.","year":"2015","unstructured":"Pirgon &#xD6;.; Sandal G.; G&#xF6;k&#xE7;en C.; Bilgin H.; D&#xFC;ndar B.; Social anxiety, depression and self-esteem in obese adolescent girls with acanthosis nigricans. J Clin Res Pediatr Endocrinol 2015,7(1),63-68","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1046\/j.1525-1470.2003.20314.x","volume":"20","author":"Uyttendaele H.","year":"2003","unstructured":"Uyttendaele H.; Koss T.; Bagheri B.; Generalized acanthosis nigricans in an otherwise healthy young child. Pediatr Dermatol 2003,20(3),254-256","journal-title":"Pediatr Dermatol"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2147\/CCID.S137527","volume":"11","author":"Patel N.U.","year":"2018","unstructured":"Patel N.U.; Roach C.; Alinia H.; Huang W.W.; Feldman S.R.; Current treatment options for acanthosis nigricans. Clin Cosmet Investig Dermatol 2018,11,407-413","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/dth.12224","volume":"28","author":"Schwartz R.A.","year":"2015","unstructured":"Schwartz R.A.; Efficacy of topical 0.1% adapalene gel for use in the treatment of childhood acanthosis nigricans: A pilot study. Dermatol Ther 2015,28(4),266","journal-title":"Dermatol Ther"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/0019-5154.147838","volume":"60","author":"Treesirichod A.","year":"2015","unstructured":"Treesirichod A.; Chaithirayanon S.; Wongjitrat N.; Wattanapan P.; The efficacy of topical 0.1% adapalene gel for use in the treatment of childhood acanthosis nigricans: A pilot study. Indian J Dermatol 2015,60(1),103","journal-title":"Indian J Dermatol"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/pde.13799","volume":"36","author":"Treesirichod A.","year":"2019","unstructured":"Treesirichod A.; Chaithirayanon S.; Wongjitrat N.; Comparison of the efficacy and safety of 0.1% adapalene gel and 0.025% tretinoin cream in the treatment of childhood acanthosis nigricans. Pediatr Dermatol 2019,36(3),330-334","journal-title":"Pediatr Dermatol"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"00222","DOI":"10.1016\/j.jaad.2021.01.065","volume":"S0190-9622","author":"Baldissera RL","year":"2021","unstructured":"Baldissera RL; Yang EJ; Schmitt JV; Lin E; Emanuel de Jesus F; Trichloroacetic acid peels for the treatment of acanthosis nigricans. J Am Acad Dermatol 2021,S0190-9622(21),00222-X","journal-title":"J Am Acad Dermatol"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/09546634.2012.674194","volume":"25","author":"Zayed A.","year":"2014","unstructured":"Zayed A.; Sobhi R.M.; Abdel Halim D.M.; Using trichloroacetic acid in the treatment of acanthosis nigricans: A pilot study. J Dermatolog Treat 2014,25(3),223-225","journal-title":"J Dermatolog Treat"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"14514","DOI":"10.1111\/jocd.14514","volume":"2021","author":"Treesirichod A.","year":"2021","unstructured":"Treesirichod A.; Chuenboonngarm S.; Kritsanaviparkporn C.; The efficacy and safety of 20% urea cream and 10% urea cream in the treat-ment of acanthosis nigricans in adolescents, a randomized comparative double-blind study. J Cosmet Dermatol 2021,2021,14514","journal-title":"J Cosmet Dermatol"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1080\/09546634.2019.1708855","volume":"32","author":"Treesirichod A.","year":"2021","unstructured":"Treesirichod A.; Chaithirayanon S.; Chaikul T.; Chansakulporn S.; The randomized trials of 10% urea cream and 0.025% tretinoin cream in the treatment of acanthosis nigricans. J Dermatolog Treat 2021,32(7),837-842","journal-title":"J Dermatolog Treat"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/pde.14404","volume":"38","author":"Coerdt K.M.","year":"2021","unstructured":"Coerdt K.M.; Todd S.P.; DeKlotz C.M.C.; Topical rapamycin for acanthosis nigricans in the Fitzpatrick IV\/V adolescent population. Pediatr Dermatol 2021,38(1),296-298","journal-title":"Pediatr Dermatol"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"2021-8-6","DOI":"10.7573\/dic.2021-8-6","volume":"2021","author":"Leung A.K.","year":"2021","unstructured":"Leung A.K.; Barankin B.; Lam J.M.; Leong K.F.; Hon K.L.; Dermatology: How to manage acne vulgaris. Drugs Context 2021,2021,2021-8-6","journal-title":"Drugs Context"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"e281","DOI":"10.1111\/pde.13206","volume":"34","author":"Giri D.","year":"2017","unstructured":"Giri D.; Alsaffar H.; Ramakrishnan R.; Acanthosis nigricans and its response to metformin. Pediatr Dermatol 2017,34(5),e281-e282","journal-title":"Pediatr Dermatol"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"e13660","DOI":"10.1111\/dth.13660","volume":"33","author":"Rizzo A.","year":"2020","unstructured":"Rizzo A.; Tognetti L.; Rubegni P.; Cinotti E.; Acanthosis nigricans monstre successfully treated with topical tacalcitol, metformin, and oral contraceptives. Dermatol Ther 2020,33(4),e13660","journal-title":"Dermatol Ther"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jocd.14224","volume":"21","author":"Abu Oun A.A.","year":"2021","unstructured":"Abu Oun A.A.; Ahmed N.A.; Hafiz H.S.A.; Comparative study between fractional carbon dioxide laser versus retinoic acid chemical peel in the treatment of acanthosis nigricans. J Cosmet Dermatol 2021,21(3),1023-1030","journal-title":"J Cosmet Dermatol"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"bcr2016216073","DOI":"10.1136\/bcr-2016-216073","volume":"2016","author":"Campos M.A.","year":"2016","unstructured":"Campos M.A.; Varela P.; Baptista A.; Ferreira E.O.; Unilateral nevoid acanthosis nigricans treated with CO2 laser. BMJ Case Rep 2016,2016,bcr2016216073","journal-title":"BMJ Case Rep"},{"key":"ref=200","first-page":"290","volume":"7","author":"Ehsani A.","year":"2016","unstructured":"Ehsani A.; Noormohammadpour P.; Goodarzi A.; Comparison of long-pulsed alexandrite laser and topical tretinoin-ammonium lactate in axillary acanthosis nigricans: A case series of patients in a before-after trial. Caspian J Intern Med 2016,7(4),290-293","journal-title":"Caspian J Intern Med"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/jocd.14088","volume":"21","author":"Eldeeb F.","year":"2022","unstructured":"Eldeeb F.; Wahid R.M.; Alakad R.; Fractional carbon dioxide laser versus trichloroacetic acid peel in the treatment of pseudo-acanthosis nig-ricans. J Cosmet Dermatol 2022,21(1),247-253","journal-title":"J Cosmet Dermatol"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s10103-019-02944-9","volume":"35","author":"Leerapongnan P.","year":"2020","unstructured":"Leerapongnan P.; Jurairattanaporn N.; Kanokrungsee S.; Udompataikul M.; Comparison of the effectiveness of fractional 1550-nm erbium fiber laser and 0.05% tretinoin cream in the treatment of acanthosis nigricans: A prospective, randomized, controlled trial. Lasers Med Sci 2020,35(5),1153-1158","journal-title":"Lasers Med Sci"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1001\/archderm.1988.01670070082026","volume":"124","author":"Sherertz E.F.","year":"1988","unstructured":"Sherertz E.F.; Improved acanthosis nigricans with lipodystrophic diabetes during dietary fish oil supplementation. Arch Dermatol 1988,124(7),1094-1096","journal-title":"Arch Dermatol"}],"container-title":["Current Pediatric Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573396318666220429085231","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/204243\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573396318666220429085231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T12:54:43Z","timestamp":1676552083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/204243\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":203,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573396318666220429085231","relation":{},"ISSN":["1573-3963"],"issn-type":[{"value":"1573-3963","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-01-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}